Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30017029HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047835HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047836HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047837HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047838HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047839HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS20020749HPVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS20020750HPVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TCGA Plot Options
Drug Information
GenePDE4A
DrugBank IDDB00651
Drug NameDyphylline
Target IDBE0001133
UniProt IDP27815
Regulation Typeinhibitor
PubMed IDs17139284; 17016423; 11752352; 225216; 7925603
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Iancu L, Shneur A, Cohen H: Trials with xanthine derivatives in systemic treatment of psoriasis. Dermatologica. 1979;159(1):55-61.@@Hariton C: Ocular hypotension induced by topical dopaminergic drugs and phosphodiesterase inhibitors. Eur J Pharmacol. 1994 Jun 2;258(1-2):85-94.
GroupsApproved
Direct ClassificationXanthines
SMILESCN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O
Pathways
PharmGKBPA164748027
ChEMBLCHEMBL1752